Authors


Mark H. O'Hara, MD

Latest:

Favorable Results Seen With APX005M in Combination Therapy for Metastatic Ductal Pancreatic Adenocarcinoma

Cancer Network spoke with Mark H. O'Hara, MD, about the safety and efficacy of APX005M in combination with standard chemotherapy with or without nivolumab.


Jennie Williams, PhD

Latest:

Does Tumor Biology Play a Role in Colon Cancer Racial Disparities?

Cancer Network spoke with Jennie Williams, PhD, and Jenny Paredes, a PhD student, about how tumor biology impacts chemotherapy response in African American vs Caucasian patients.


Jim Kling

Latest:

Breast Cancer Screening Can Begin Later in Childhood Cancer Survivors

Research evaluated whether initiating breast cancer screening at age 30 may be preferable to current guidelines among survivors of childhood cancer with a history of chest irradiation.


Hank Schmidt, MD

Latest:

Dr. Schmidt on AMAROS Trial Results: Radiotherapy vs Surgery of the Axilla in Breast Cancer

Cancer Network spoke with Hank Schmidt, MD, about the 10-year follow-up results of the EORTC AMAROS trial of radiotherapy vs surgery of the axilla in breast cancer patients with a positive sentinel node.


Lauren M. Dembeck

Latest:

CheckMate 204: New First-Line Therapy for Asymptomatic Melanoma Brain Metastases?

The results of the phase II trial examining combination immunotherapy were presented during the ASCO 2019 meeting.


Scarlett Lin Gomez, PhD

Latest:

Can Social and Environmental Factors Cause Cancer Disparities?

Cancer Network spoke with Dr. Scarlett Lin Gomez about the role gender, socioeconomic status, race/ethnicity, and neighborhood characteristics have on health outcomes in cancer.


Carlos A. Lopez, MD, MPH

Latest:

Non–Small-Cell Lung Cancer After Mantle Radiation: A Case Report and Brief Review

In this case report, we present a non-Hodgkin lymphoma survivor who was incidentally found to have non–small-cell lung cancer 30 years after undergoing treatment that included mantle radiation. We discuss the treatment-related risk factors for lung cancer in this population and potential implications for long-term follow-up.


Abhinav Gupta

Latest:

The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

This case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?



Sameer Nath, MD

Latest:

The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

This case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?


Kimberly Johung, MD, PhD

Latest:

When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy

This review summarizes the current evidence supporting the use of SBRT as treatment for inoperable renal cell carcinoma, as well as provides recommendations for patient selection and reviews the technical aspects of treatment and the expected toxicities.


Avyakta Kallam, MD

Latest:

Overcoming Physical and Social Barriers in the Lymphoma Field

Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.


Frank A. Sinicrope, MD

Latest:

Evaluating Immunotherapy in Nonmetastatic Colorectal Cancer

Dr. Sinicrope reviews the phase III ATOMIC trial, which is testing standard chemotherapy alone or in combination with the anti–PD-L1 antibody atezolizumab as adjuvant therapy in a subset of colon cancer patients.


Ruth Oratz, MD

Latest:

Dr. Oratz on PARP Inhibitors to Treat Patients With Breast Cancer

Cancer Network spoke with Ruth Oratz, MD, a medical oncologist at NYU Langone Perlmutter Cancer Center in New York City, about the use of PARP inhibitors for breast cancer.


Claude Cyr, MD

Latest:

Using Cannabis as a Palliative Treatment in Patients With Cancer

Ahead of the ASCO Annual Meeting, we discuss the use of cannabis as a palliative treatment in patients with cancer with Claude Cyr, MD.


Elizabeth Shpall, MD

Latest:

Managing Cytokine Release Syndrome in Patients on CAR T-Cell Therapy

Ahead of the ASCO Annual Meeting, we discuss the assessment and management of cytokine release syndrome in patients with cancer with Elizabeth Shpall, MD.


Meagan S. Barbee, PharmD, BCOP

Latest:

Considerations When Initiating Neratinib for Breast Cancer: How to Prevent and Treat Diarrhea

An oncology pharmacist discusses how to prevent and treat diarrhea in patients taking neratinib for breast cancer.


Abhishek Bhat, MD

Latest:

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.


Sanoj Punnen, MD, MAS

Latest:

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.


Ikenna Madueke, MD, PhD

Latest:

Counterpoint: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

In this Point/Counterpoint, Drs. Madueke and Abern argue that active surveillance should not currently be considered for patients with intermediate-risk prostate cancer.


Vicky Makker, MD

Latest:

Breaking New Ground in the Treatment of Advanced Endometrial Cancer

Dr. Makker summarizes the standard of care for the treatment of advanced endometrial cancer, with a look forward to the multitude of clinical trials evaluating novel therapy combinations that are currently enrolling patients or underway.


Leah Walsh, MS

Latest:

Suicide in Patients With Cancer: Identifying the Risk Factors

This article reviews the prevalence of suicide in patients with cancer, risk factors, related conditions, and interventions to identify and treat suicidal patients.


Stephanie Napolitano, MA

Latest:

Suicide in Patients With Cancer: Identifying the Risk Factors

This article reviews the prevalence of suicide in patients with cancer, risk factors, related conditions, and interventions to identify and treat suicidal patients.


Jody Morita, MD

Latest:

Personality Disorders in Patients with Cancer

Personality disorders become exacerbated under stressful cancer-related situations and may lead to adverse consequences and outcomes.


Reena Jaiswal, MD

Latest:

Suicide in Patients With Cancer: Identifying the Risk Factors

This article reviews the prevalence of suicide in patients with cancer, risk factors, related conditions, and interventions to identify and treat suicidal patients.


Keith T. Wilson, MD

Latest:

Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection

Dr. Wilson discusses a chemopreventive drug that may help prevent gastric cancer by acting directly on H. pylori.


Karine Turcotte, MD

Latest:

Progressive Red-to-Violaceous Papules and Plaques on the Neck and Abdominal Skin of a 70-Year-Old Woman

A 70-year-old woman developed red-to-violaceous papules, plaques, and nodule- like skin lesions several months prior to her presentation. The skin lesions mostly involved her lower neck and abdominal area. What is the most likely diagnosis?


Hey Min Lee

Latest:

Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer

In this article, we review the characteristics of the BRAF mutation and the evolving strategies for managing BRAF-mutant metastatic colorectal cancer.


Van Morris, MD

Latest:

Clinical Trials in Progress: COBRA

Phase 2/3 Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA): a first-in-kind trial seeks to provide level 1 evidence in evaluating the role of ctDNA as a guide for clinicians in the decision to administer adjuvant chemotherapy to patients with stage IIA colon cancer (NRG GI-005) (NCT04068103).


Stefania Napolitano, MD

Latest:

Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer

In this article, we review the characteristics of the BRAF mutation and the evolving strategies for managing BRAF-mutant metastatic colorectal cancer.